Functional immunoassay technology (FIT), a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR).
Functional immunoassay technology (FIT), a new approach for measuring physiological functions: application of FIT to measure glomerular filtration rate (GFR).
复制标题
功能免疫分析技术(FIT),一种测量生理功能的新方法:应用FIT测量肾小球滤过率(GFR)。
DOI:
10.1152/ajprenal.90354.2008
复制
发表时间:
2008
期刊:
影响因子:
--
通讯作者:
Vaccaro,DennisE
中科院分区:
文献类型:
--
作者:
Reinhardt,ChristopherPeter;Germain,MichaelJ;Groman,ErnestV;Mulhern,JeffreyG;Kumar,Rajesh;Vaccaro,DennisE
This is the first description of functional immunoassay technology (FIT), which as a diagnostic tool has broad application across the whole spectrum of physiological measurements. In this paper, FIT is used to measure the renal clearance of an ultra low-dose administration of a clinically available contrast reagent for the purpose of obtaining an accurate glomerular filtration rate (GFR) measurement. Biomarker-based GFR estimates offer convenience, but are not accurate and are often misleading. FIT overcomes previous analytic barriers associated with obtaining an accurate GFR measurement. We present the performance characteristics of this diagnostic test and demonstrate the method by directly comparing GFR values obtained by FIT to those obtained by an FDA approved nuclear test in 20 adults. Two subjects were healthy volunteers and the remaining 18 subjects had diagnosed chronic kidney disease, with 12 being kidney transplant recipients. Measured GFR values were calculated by the classic UV/P method and by the blood clearance method. GFR obtained by FIT and the nuclear test correlated closely over a wide range of GFR values (10.9–102.1 ml·min−1·1.73 m−2). The study demonstrates that FIT-GFR provides an accurate and reproducible measurement. This nonradioactive, immunoassay-based approach offers many advantages, chiefly that most laboratories already have the equipment and trained personnel necessary to run an ELISA, and therefore this important diagnostic measurement can more readily be obtained. The FIT-GFR test can be used throughout the pharmaceutical development pipeline: preclinical and clinical trials.
登录
查看更多内容
影响因子:
13.6
作者:
White, C;Akbari, A;Knoll, GA
通讯作者:
Knoll, GA
影响因子:
8.8
作者:
Poggio, ED;Wang, X;Hall, R
通讯作者:
Hall, R
DOI:
10.1007/bf00817277
发表时间:
1995
期刊:
European Journal of Nuclear Medicine
影响因子:
--
作者:
A. Biggi;A. Viglietti;M. C. Farinelli;C. Bonada;G. Camuzzini
通讯作者:
G. Camuzzini
影响因子:
8.8
作者:
Gera, M.;Slezak, J. M.;Cosio, F. G.
通讯作者:
Cosio, F. G.
影响因子:
8.8
作者:
Mariat, C;Alamartine, E;Berthoux, F
通讯作者:
Berthoux, F